Polo-Like Kinase 1 Is a Therapeutic Target in High-Risk Neuroblastoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-1129
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)